ResearcherThe University of Texas Health Science Center at HoustonNo recent work listed

Yiping Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2188-6958; OpenAlex author ID A5100628291. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper

Papers 1

Patient-Derived Pancreatic Cancer Cells Induce C2C12 Myotube Atrophy by Releasing Hsp70 and Hsp90. Last author DOI 10.3390/cells11172756 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Vignesh Vudatha · 1 shared paper, 2022 · strength 0.17
- Paper Patient-Derived Pancreatic Cancer Cells Induce C2C12 Myotube Atrophy by Releasing Hsp70 and Hsp90. DOI 10.3390/cells11172756 ↗
Hongyu Wu · 1 shared paper, 2022 · strength 0.17
- Paper Patient-Derived Pancreatic Cancer Cells Induce C2C12 Myotube Atrophy by Releasing Hsp70 and Hsp90. DOI 10.3390/cells11172756 ↗
Andrea N. Riner · 1 shared paper, 2022 · strength 0.17
- Paper Patient-Derived Pancreatic Cancer Cells Induce C2C12 Myotube Atrophy by Releasing Hsp70 and Hsp90. DOI 10.3390/cells11172756 ↗
Jose Gilberto Trevino · 1 shared paper, 2022 · strength 0.17
- Paper Patient-Derived Pancreatic Cancer Cells Induce C2C12 Myotube Atrophy by Releasing Hsp70 and Hsp90. DOI 10.3390/cells11172756 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.